What is considered an increased Pulsatility Index (PI) percentile in the ductus venosus on fetal ultrasound?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Increased Ductus Venosus Pulsatility Index on Fetal Ultrasound

An increased ductus venosus pulsatility index (PI) is defined as a value above the 95th percentile for gestational age, though abnormality is primarily determined by qualitative waveform analysis showing decreased, absent, or reversed flow during atrial contraction (the A-wave), rather than by PI percentile alone. 1

Primary Definition of Abnormality

The most clinically significant abnormality in ductus venosus Doppler assessment is qualitative waveform analysis, not the PI percentile:

  • Decreased, absent, or reversed flow in the A-wave (during atrial contraction) represents the key abnormal finding linked to adverse outcomes 1
  • This waveform abnormality indicates myocardial impairment and increased ventricular end-diastolic pressure from elevated right ventricular afterload 1
  • These abnormal waveforms are directly linked to neonatal acidemia and perinatal mortality in growth-restricted fetuses 1

Pulsatility Index Percentile Thresholds

When PI values are used quantitatively, the following thresholds define abnormality:

  • >95th percentile is the standard cutoff for abnormally increased ductus venosus PI 2, 3
  • >90th percentile has been associated with increased risk for chromosomal abnormalities, small for gestational age infants, and low birth weight 4
  • In first-trimester screening for trisomy 21,73% of affected fetuses showed PI values >95th percentile 2

Clinical Context and Timing

The interpretation varies by gestational age and clinical scenario:

  • First trimester (10-18 weeks): Increased PI >95th percentile is associated with chromosomal abnormalities, particularly trisomy 21, and predicts later fetal growth restriction 2, 4
  • Second and third trimester (≥23 weeks): Focus shifts to qualitative A-wave assessment in growth-restricted fetuses, where abnormal waveforms indicate cardiovascular decompensation 1
  • Normal ductus venosus shows continuous forward flow throughout the cardiac cycle with a biphasic waveform pattern 1

Important Technical Considerations

Common pitfalls to avoid:

  • Mistaking the inferior vena cava for the ductus venosus is the most frequent technical error 1
  • Proper identification requires color Doppler showing aliasing (mixture of colors) at the site where the ductus venosus branches from the umbilical vein 1
  • Measurements should be obtained in transverse or sagittal views of the fetal abdomen at the diaphragm level 1

Clinical Significance

The strength of evidence prioritizes waveform morphology over PI percentiles because:

  • Abnormal A-wave flow has direct correlation with neonatal acidemia and mortality in intrauterine growth restriction 1
  • This represents late-stage cardiovascular compromise requiring urgent clinical decision-making 1
  • PI percentiles are more useful for early screening (first trimester) rather than acute fetal assessment 2, 4

In practice, when evaluating a growth-restricted fetus, the presence of absent or reversed A-wave flow is more clinically actionable than a mildly elevated PI percentile, as it indicates imminent cardiovascular decompensation requiring delivery consideration. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.